QF
TCON

QVT Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

QVT Financial’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-117
Closed -$15K – 52
2018
Q4 		$15K Hold
117
– – ﹤0.01% 51
2018
Q3 		$48K Hold
117
– – 0.01% 52
2018
Q2 		$63K Sell
117
-112
-49% -$59.6K 0.02% 50
2018
Q1 		$102K Sell
229
-396
-63% -$216K 0.01% 52
2017
Q4 		$397K Sell
625
-916
-59% -$553K 0.02% 58
2017
Q3 		$916K Sell
1,541
-157
-9% -$81.8K 0.03% 64
2017
Q2 		$815K Hold
1,698
– – 0.02% 67
2017
Q1 		$1.27M Sell
1,698
-209
-11% -$187K 0.04% 72
2016
Q4 		$1.71M Buy
1,907
+236
+14% +$270K 0.05% 81
2016
Q3 		$2.01M Sell
1,671
-145
-8% -$163K 0.08% 65
2016
Q2 		$1.41M Hold
1,816
– – 0.1% 72
2016
Q1 		$2.31M Hold
1,816
– – 0.14% 79
2015
Q4 		$3.36M Hold
1,816
– – 0.19% 73
2015
Q3 		$3.55M Sell
1,816
-26
-1% -$60.8K 0.12% 77
2015
Q2 		$4.1M Hold
1,842
– – 0.06% 75
2015
Q1 		$5M Buy
+1,842
New +$4.84M 0.28% 64

Other funds holding TCON

PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

QVT Financial's TCON Position: Q1 2019 in Review

QVT Financial sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2019, closing a stake of 117 shares — an estimated $15K sold.

QVT Financial first reported a position in TCON in Q1 2015 and held it in 16 quarters. The position peaked at $5M in Q1 2015. 24 funds tracked by Wall St. Rank hold TCON as of Q1 2019.

  • QVT Financial reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • QVT Financial sold 117 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $15K.
  • QVT Financial first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
  • QVT Financial's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $5M in Q1 2015.
  • 24 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on QVT Financial's 13F filing for Q1 2019, filed 15 May 2019.